ArticlePituitary2025

Non-penetrant Xq26.3 duplication involving the invariant TAD border: clinical evidence for the VGLL1 region as the GPR101 pituitary enhancer of X-linked acrogigantism.

Cathie Hilditch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.